23,596 reports of this reaction
3.5% of all ABATACEPT reports
#2 most reported adverse reaction
RHEUMATOID ARTHRITIS is the #2 most commonly reported adverse reaction for ABATACEPT, manufactured by E.R. Squibb & Sons, L.L.C.. There are 23,596 FDA adverse event reports linking ABATACEPT to RHEUMATOID ARTHRITIS. This represents approximately 3.5% of all 665,237 adverse event reports for this drug.
Patients taking ABATACEPT who experience rheumatoid arthritis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RHEUMATOID ARTHRITIS is moderately reported among ABATACEPT users, representing a notable but not dominant share of adverse events.
In addition to rheumatoid arthritis, the following adverse reactions have been reported for ABATACEPT:
The following drugs have also been linked to rheumatoid arthritis in FDA adverse event reports:
RHEUMATOID ARTHRITIS has been reported as an adverse event in 23,596 FDA reports for ABATACEPT. This does not prove causation, but indicates an association observed in post-market surveillance data.
RHEUMATOID ARTHRITIS accounts for approximately 3.5% of all adverse event reports for ABATACEPT, making it one of the most commonly reported side effect.
If you experience rheumatoid arthritis while taking ABATACEPT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.